Taken together, these findings suggest that blocking CB1R at the periphery reverses obesity, reduces hyperphagia, and improves metabolic outcomes in obese Magel2-null mice. Here, MAGEL2 is linked to obesity due to melanocortin 4 receptor deficiency.